Overview
- 18 inspections across 18 sites are on record.
- 77 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-04.
At a glance
Inspections
18
Sites
18
Observations
77
Career since
Apr 2024
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Bachem Americas, Inc. | 4 May 2026 | Human Drugs | On file |
| KDC/ONE SOCAL LABORATORIES, LLC | 14 Apr 2026 | Human Drugs | View 483 → |
| Dr. J Skinclinic, Inc | 23 Mar 2026 | Human Drugs | View 483 → |
| Pyramid Laboratories, Inc. | 13 Feb 2026 | Human Drugs | View 483 → |
| Merle Norman Cosmetics, Inc. | 21 Nov 2025 | Human Drugs | View 483 → |
Sites inspected
Bachem Americas, Inc.Torrance, United States1 insp.
KDC/ONE SOCAL LABORATORIES, LLCWalnut, United States1 insp.
Dr. J Skinclinic, IncCerritos, United States1 insp.
Pyramid Laboratories, Inc.Costa Mesa, United States1 insp.
Merle Norman Cosmetics, Inc.Los Angeles, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Darren S Brown4 shared
Andrew Le4 shared
Thuy Tram L Nguyen3 shared
Ngozi G Offor3 shared
Gloria E Andia2 shared
Cecilia H Kieu2 shared
Joan M Cantellops Figueroa2 shared
Claudia M Perez-Kasmarski2 shared
Joshua S Lee1 shared
Devisree P Mattigiri1 shared
Full investigator report
Get the verbatim findings behind Navneet Kaur's 77 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site